Evidence map›Paper›PMID 31138801›Full record

ArticleNature communications2019

The origin of heterogeneous nanoparticle uptake by cells.

Paul Rees, John W Wills, M Rowan Brown, Claire M Barnes, Huw D Summers

Abstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paul ReesCentre for Nanohealth, Swansea University College of Engineering, Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, UK. p.rees@swansea.ac.uk.
John W WillsBiominerals Research, Cambridge University Department of Veterinary Medicine, School of Biological Sciences, Madingley Road, Cambridge, CB3 0ES, UK. jw2020@cam.ac.uk.
M Rowan BrownCentre for Nanohealth, Swansea University College of Engineering, Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, UK.
Claire M BarnesCentre for Nanohealth, Swansea University College of Engineering, Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, UK.
Huw D SummersCentre for Nanohealth, Swansea University College of Engineering, Fabian Way, Crymlyn Burrows, Swansea, SA1 8EN, UK.

Funding

TRANSITION METAL MEDIATED SYNTHESIS OF ORTHO-QUINONESF32CA008683 · NCI · EMORY UNIVERSITY · PI HUFFMAN, MARK A · 1989 to 1991
–
RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/N005163/1RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/P026818/1RCUK | Engineering and Physical Sciences Research Council (EPSRC) EP/H008683/1
6 · The paper itself

Abstract

Understanding nanoparticle uptake by biological cells is fundamentally important to wide-ranging fields from nanotoxicology to drug delivery. It is now accepted that the arrival of nanoparticles at the cell is an extremely complicated process, shaped by many factors including unique nanoparticle physico-chemical characteristics, protein-particle interactions and subsequent agglomeration, diffusion and sedimentation. Sequentially, the nanoparticle internalisation process itself is also complex, and controlled by multiple aspects of a cell's state. Despite this multitude of factors, here we demonstrate that the statistical distribution of the nanoparticle dose per endosome is independent of the initial administered dose and exposure duration. Rather, it is the number of nanoparticle containing endosomes that are dependent on these initial dosing conditions. These observations explain the heterogeneity of nanoparticle delivery at the cellular level and allow the derivation of simple, yet powerful probabilistic distributions that accurately predict the nanoparticle dose delivered to individual cells across a population.

Indexed as

A549 CellsBiological TransportCell LineEndosomesHigh-Throughput Screening AssaysHumansImage Processing, Computer-AssistedMicroscopy, ConfocalNanoparticles

Identifiers

PMID31138801
PMCPMC6538724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.